Skip to main content
. 2019 Nov 12;6:170. doi: 10.3389/fnut.2019.00170

Table 4.

Comparing the effects of emulsions stability and redispersibility on gastrointestinal hormone profiles between rats and humans after intake of the three different LEs (LE1, acid stable LE; LE3, non-redispersible acid unstable LE with solid fat; LE4, redispersible acid unstable LE; CCK, cholecystokinin; PYY, peptide YY; GLP-1, glucagon-like peptide 1; BHB, betahydroxybutyrate; FFA, free fatty acids).

Measure Effect Rat Human
GLP-1 ΔAmax31, pg/mL −19 (−28 to −11) −3.0 (−6.4, 0.2) Acid instability (LE3, LE4)
ΔAmax41, pg/mL −17 (−26 to −10) −2.6 (−5.4, 0.5) → lower GLP-1 peak in rats and in humans
ΔAOB41, pg/mL·h −39 (−59 to −13) −3 (−57, 75) Acid instability and redispersibility (LE4)
→ less GLP-1 release only in rats
PYY ΔAmax31, pg/mL −240 (−332 to −166) −47 (−79, −19) Acid instability (LE3, LE4)
ΔAmax41, pg/mL −166 (−266 to −108) −44 (−79, −15) → lower PYY peak in rats and humans
Δtmax41, min −26 (−47 to −4) −178 (−369, −39) Acid instability and redispersibility (LE4)
Δtmax43, min −94 (−142 to −50) −336 (−802, −31) → earlier PYY peak in rats and humans
ΔAOB31, pg/mL·h −354 (−579 to −104) −343 (−912, 522) Acid instability and no redispersibility (LE3)
→ less PYY release only in rats
Δtmax31, min 65 (35 to 123) 151 (−132, 599) Acid instability and no redispersibility (LE3)
→ delayed PYY peak only in rats
TAG Δtmax31, min 53 (12 to 99) −146 (−352, 11) Acid instability and no redispersibility (LE3)
→ earlier TAG peak only in rats
dAmax31 −0.1 (−0.2, 0.1) −0.4 (−0.6, −0.2) Acid instability and no redispersibility (LE3)
dAOB31 4 (−35, 47) −236 (−439, −105) → lower TAG peak and release only in humans
BHB Δtmax31, min 35 (0.5 to 76) 42 (−169, 216) Acid instability and no redispersibility (LE3)
→ delayed BHB peak only in rats
FFA No emulsion effect neither in rats nor in humans